Fusobacterium nucleatum downregulated MLH1 expression in colorectal cancer by activating autophagy-lysosome pathway
BackgroundsFusobacterium nucleatum (F. nucleatum) has been shown to be associated with immunotherapy in colorectal cancer (CRC), but its exact mechanism needs to be further explored.MethodsWe first analyzed the correlation between F. nucleatum abundance and mismatch repair (MMR) protein deficiency i...
Saved in:
| Main Authors: | Tingting Ding, Minkang Wu, Li Zhao, Hu Liu, Xuanke Cao, Jing Guo, Xingchen Zhu, Lamei Zhao, Heping Zhang, Yaohui Gao, Qing Wei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1586146/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fusobacterium nucleatum Abundance is Associated with Cachexia in Colorectal Cancer Patients: The ColoCare Study
by: Mmadili N. Ilozumba, et al.
Published: (2024-11-01) -
Abscesses of the spine and iliac fossa caused by infection with the opportunistic bacterium Fusobacterium nucleatum
by: YunTao Gu, et al.
Published: (2025-01-01) -
Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance
by: Chun Ye, et al.
Published: (2024-12-01) -
Association of Fusobacterium nucleatum with colorectal cancer molecular subtypes and its outcome: a systematic review
by: Luana Greco, et al.
Published: (2025-01-01) -
Reexamining the role of Fusobacterium nucleatum subspecies in clinical and experimental studies
by: Madeline Krieger, et al.
Published: (2024-12-01)